Emergency room visit rates across the United States show significant variation, with a national average of 422 visits per 1,000 population in 2023. This average masks considerable differences between states, ranging from 596 visits per 1,000 population in West Virginia to just 226 in Nevada. Wait times in emergency rooms While ER visit rates provide insight into utilization, wait times offer a glimpse into the efficiency of emergency care delivery. In 2022, ER patients waited an average of 38.1 minutes to see a healthcare provider in emergency departments nationwide. Interestingly, the COVID-19 pandemic temporarily reduced wait times in 2020, but they rebounded to pre-pandemic levels by 2021. Most patients, roughly 70 percent, spend less than an hour in the emergency department before being seen by a medical professional. These figures suggest that despite high utilization in some areas, many emergency departments manage to process patients relatively quickly. Demographic disparities in emergency care Emergency department usage varies significantly across different demographic groups, revealing important healthcare access disparities. Infants under one-year-old and adults 75 years and over have the highest ED visit rates among all age groups. Additionally, racial disparities in ED rates are evident, with non-Hispanic Black individuals having double the ED visit rate of non-Hispanic White individuals. These patterns underscore the need for targeted healthcare interventions and improved access to acute care for vulnerable populations.

In 2022, emergency department visit rate was highest among infants under the age of one. Adults 75 years and over had the second-highest ED visit rate, while the average for all ages was 47 visits per 100 people in 2022.

Mean annual rate (per 10,000 person-years with 95% confidence intervals) of norovirus gastroenteritis (NGE)-attributable emergency department (ED) visits, hospitalizations and outpatient visits by age (2002–2013 MarketScan database).

Eritrea ER: Electric Power Consumption: per Capita data was reported at 64.139 kWh in 2011. This records an increase from the previous number of 61.947 kWh for 2010. Eritrea ER: Electric Power Consumption: per Capita data is updated yearly, averaging 57.112 kWh from Dec 1992 (Median) to 2011, with 20 observations. The data reached an all-time high of 64.139 kWh in 2011 and a record low of 39.441 kWh in 1992. Eritrea ER: Electric Power Consumption: per Capita data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Eritrea – Table ER.World Bank: Energy Production and Consumption. Electric power consumption measures the production of power plants and combined heat and power plants less transmission, distribution, and transformation losses and own use by heat and power plants.; ; IEA Statistics © OECD/IEA 2014 (http://www.iea.org/stats/index.asp), subject to https://www.iea.org/t&c/termsandconditions/; Weighted average; Restricted use: Please contact the International Energy Agency for third-party use of these data.

Number and mean incidence rate (per 10,000 person-years) of all-cause (AGE) and norovirus gastroenteritis (NGE)-attributable emergency department visits, outpatient visits and hospitalizations (2002–2013, MarketScan database).

Among OECD countries in 2022, South Korea had the highest rate of yearly visits to a doctor per capita. On average, people in South Korea visited the doctors 15.7 times per year in person. Health care utilization is an important indicator of the success of a country’s health care system. There are many factors that affect health care utilization including healthcare structure and the supply of health care providers.

OECD health systems

Healthcare systems globally include a variety of tools for accessing healthcare, including private insurance based systems, like in the U.S., and universal systems, like in the U.K. Health systems have varying costs among the OECD countries. Worldwide, Europe has the highest expenditures for health as a proportion of the GDP. Among all OECD countries, The United States had the highest share of government spending on health care. Recent estimates of current per capita health expenditures showed the United States also had, by far, the highest per capita spending on health worldwide.

Supply of health providers

Globally, the country with the highest physician density is Cuba, although most other countries with high number of physicians to population was found in Europe. The number of graduates of medicine impacts the number of available physicians in countries. Among OECD countries, Latvia had the highest rate of graduates of medicine, which was almost twice the rate of the OECD average.

Mental health service use over 12 months for individuals with at least one acute care or outpatient mental health visit (n = 1,478).

This table contains 165 series, with data for years 2011-2019 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (11 items: Canada; Newfoundland and Labrador; Prince Edward Island; Nova Scotia; ...) ; Energy type (4 items: Total, all energy types; Electricity; Natural gas; Heating oil) ; Energy consumption (4 items: Gigajoules; Gigajoules per household; Proportion of total energy; Number of households).

Costs in Canadian dollars of mental healthcare for those with at least one visit (n = 1,478).

The average number of hospital beds available per 1,000 people in the United States was forecast to continuously decrease between 2024 and 2029 by in total 0.1 beds (-3.7 percent). After the eighth consecutive decreasing year, the number of available beds per 1,000 people is estimated to reach 2.63 beds and therefore a new minimum in 2029. Depicted is the number of hospital beds per capita in the country or region at hand. As defined by World Bank this includes inpatient beds in general, specialized, public and private hospitals as well as rehabilitation centers.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to 150 countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the average number of hospital beds available per 1,000 people in countries like Canada and Mexico.

Demographic and clinical characteristics (N = 3,410).

Factors associated with acute care use (N = 3,410).

In 2023, there were over **** million hospital admissions in the United States. The number of hospitals in the U.S. has decreased in recent years, although the country faces an increasing elder population. Predictably, the elderly account for the largest share of hospital admissions in the U.S. Hospital stays Stays in hospitals are more common among females than males, with around *** percent of females reporting one or more hospital stays in the past year, compared to *** percent of males. Furthermore, **** percent of those aged 65 years and older had a hospitalization in the past year, compared to just *** percent of those aged 18 to 44 years. The average length of a stay in a U.S. hospital is *** days. Hospital beds In 2022, there were ******* hospital beds in the U.S. In the past few years, there has been a decrease in the number of hospital beds available. This is unsurprising given the decrease in the number of overall hospitals. In 2021, the occupancy rate of hospitals in the U.S. was ** percent.

Health care utilization of patients pre and post-hospitalization due to COVID-19,c,d,e.

BackgroundBetween June and November 2017, four supervised consumption sites (SCS) began operating in Montreal, Quebec. Earlier studies on SCS focused on examining their effects on blood-borne viral infections and overdose mortality. Our objective was to examine the effect of Montreal’s SCS on the incidence, health service use and outcomes of injection-related infections (IRI) in people who inject drugs.MethodsWe used Quebec’s provincial administrative health data to identify people who inject drugs in Montreal and calculated the incidence of IRI in this population between December 2014 and December 2019. We conducted a retrospective, population-based interrupted time series to estimate the effect of Montreal’s four SCS on the monthly incidence rates of IRI-related hospitalizations, emergency department (ED) visits, physician visits, and mortality. We also examined the effects of SCS on average length of IRI-related hospitalizations and incidence of hospitalizations involving surgery.ResultsThe average age of Montreal’s people who inject drugs was 41.84 years, and 66.41% were male. After the implementation of SCS, there was a positive level change in the incidence of hospitalizations (0.97; 95% confidence interval [CI]: 0.26, 1.68) for IRI. There was also a significant post-intervention decline in hospitalization trends (-0.05; 95% CI: -0.08, -0.02), with modest trend changes in ED visits (-0.02; 95% CI: -0.05, 0.02). However, post-intervention changes in level (0.72; 95% CI: -3.85, 5.29) and trend (0.06; 95% CI: -0.23, 0.34) for physician visits remained limited. SCS had no effect on the average length of hospitalizations, but there was a decreasing post-intervention trend in hospitalizations involving surgery (-0.03; 95% CI: -0.06, 0.00).ConclusionFollowing the opening of the SCS, there was a moderate decline in the rate of hospitalizations to treat IRI, but the impact of the sites on the rate of physician visits remained limited. These findings suggest that SCS may mitigate the incidence of more serious and complicated IRI over time.

Vaccination is considered as the main tool for the Global Control and Eradication Strategy for peste des petits ruminants (PPR), and the efficacity of the PPR-vaccine in conferring long-life immunity has been established. Despite this, previous studies asserted that vaccination can be expensive and consequently, the effectiveness of disease control may not necessarily translate to overall profit for farmers. Also, the consequences of PPR control on socioeconomic indicators like food and nutrition security at a macro-national level have not been explored thoroughly. Therefore, this study seeks to assess ex-ante the impact of PPR control strategies on farm-level profitability and the socioeconomic consequences concerning food and nutrition security at a national level in Senegal. A bi-level system dynamics model, compartmentalised into five modules consisting of integrated production-epidemiological, economics, disease control, marketing, and policy modules, was developed with the STELLA Architect software, validated, and simulated for 30 years at a weekly timestep. The model was parameterised with data from household surveys from pastoral areas in Northern Senegal and relevant existing data. Nine vaccination scenarios were examined considering different vaccination parameters (vaccination coverage, vaccine wastage, and the provision of government subsidies). The findings indicate that compared to a no-vaccination scenario, all the vaccination scenarios for both 26.5% (actual vaccination coverage) and 70% (expected vaccination coverage) resulted in statistically significant differences in the gross margin earnings and the potential per capita consumption for the supply of mutton and goat meat. At the prevailing vaccination coverage (with or without the provision of government subsidies), farm households will earn an average gross margin of $69.43 (annually) more than without vaccination, and the average per capita consumption for mutton and goat meat will increase by 1.13kg/person/year. When the vaccination coverage is increased to the prescribed threshold for PPR eradication (i.e., 70%), with or without the provision of government subsidies, the average gross margin earnings would be $72.23 annually and the per capita consumption will increase by 1.23kg/person/year compared to the baseline (without vaccination). This study’s findings offer an empirical justification for a sustainable approach to PPR eradication. The information on the socioeconomic benefits of vaccination can be promoted via sensitization campaigns to stimulate farmers’ uptake of the practice. This study can inform investment in PPR control.

Texas is the leading electricity-consuming state in the United States. In 2022, the state consumed roughly 475 terawatt-hours of electricity. California and Florida followed in second and third, each consuming approximately 250 terawatt-hours.

In 2023, there were over 7.4 million people employed in hospitals across the United States. This is the highest number in the recorded time period and hospital employment numbers have returned to and surpassed pre-pandemic levels.

Characteristics of patients discharged home from COVID-19 hospitalization from April 2020 to March 2021 in the United States.

In 2023, the United States had the highest per capita health expenditure among OECD countries. At that time, per capita health expenditure in the U.S. amounted over ****** U.S. dollars, significantly higher than in Switzerland, the country with the second-highest per capita health expenditure. Norway, Germany and Austria are also within the top five countries with the highest per capita health expenditure. The United States also spent the highest share of it’s gross domestic product on health care, with **** percent of its GDP spent on health care services. Health Expenditure in the U.S. The United States is the highest spending country worldwide when it comes to health care. In 2022, total health expenditure in the U.S. exceeded **** trillion dollars. Expenditure as a percentage of GDP is projected to increase to approximately ** percent by the year 2031. Distribution of Health Expenditure in the U.S. Health expenditure in the United States is spread out across multiple categories such as nursing home facilities, home health care, and prescription drugs. As of 2022, the majority of health expenditure in the United States was spent on hospital care, accounting for a bit less than *** third of all health spending. Hospital care was followed by spending on physician and clinical services which accounted for ** percent of overall health expenditure.